Testing effectiveness (Phase 2)Study completedNCT02662972
What this trial is testing
Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues.
Who this might be right for
Trigeminal NeuralgiaHeadache Disorders
Norwegian University of Science and Technology 10